183 related articles for article (PubMed ID: 9833978)
1. Human keratinocyte line HaCaT metabolizes 1alpha-hydroxyvitamin D3 and vitamin D3 to 1alpha,25-dihydroxyvitamin D3 (calcitriol).
Lehmann B; Pietzsch J; Kämpf A; Meurer M
J Dermatol Sci; 1998 Nov; 18(2):118-27. PubMed ID: 9833978
[TBL] [Abstract][Full Text] [Related]
2. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
Astecker N; Bobrovnikova EA; Omdahl JL; Gennaro L; Vouros P; Schuster I; Uskokovic MR; Ishizuka S; Wang G; Reddy GS
Arch Biochem Biophys; 2004 Nov; 431(2):261-70. PubMed ID: 15488475
[TBL] [Abstract][Full Text] [Related]
3. Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents.
Lehmann B; Rudolph T; Pietzsch J; Meurer M
Exp Dermatol; 2000 Apr; 9(2):97-103. PubMed ID: 10772383
[TBL] [Abstract][Full Text] [Related]
4. HaCaT cell line as a model system for vitamin D3 metabolism in human skin.
Lehmann B
J Invest Dermatol; 1997 Jan; 108(1):78-82. PubMed ID: 8980292
[TBL] [Abstract][Full Text] [Related]
5. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
[TBL] [Abstract][Full Text] [Related]
6. Isolation and identification of 1alpha-hydroxy-24-oxovitamin D3 and 1alpha,23-dihydroxy-24-oxovitamin D3: metabolites of 1alpha,24(R)-dihydroxyvitamin D3 produced in rat kidney.
Weinstein EA; Rao DS; Siu-Caldera ML; Tserng KY; Uskokovic MR; Ishizuka S; Reddy GS
Biochem Pharmacol; 1999 Dec; 58(12):1965-73. PubMed ID: 10591152
[TBL] [Abstract][Full Text] [Related]
7. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation.
Kamao M; Tatematsu S; Hatakeyama S; Sakaki T; Sawada N; Inouye K; Ozono K; Kubodera N; Reddy GS; Okano T
J Biol Chem; 2004 Apr; 279(16):15897-907. PubMed ID: 14757768
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, stereochemistry, and biological activity of 1alpha,23,25-trihydroxy-24-oxovitamin D3, a major natural metabolite of 1alpha,25-dihydroxyvitamin D3.
Lee NE; Reddy GS; Brown AJ; Williard PG
Biochemistry; 1997 Aug; 36(31):9429-37. PubMed ID: 9235987
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.
Itin PH; Pittelkow MR; Kumar R
Endocrinology; 1994 Nov; 135(5):1793-8. PubMed ID: 7956903
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3.
Tuckey RC; Janjetovic Z; Li W; Nguyen MN; Zmijewski MA; Zjawiony J; Slominski A
J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):213-9. PubMed ID: 19000766
[TBL] [Abstract][Full Text] [Related]
12. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes.
Matsumoto K; Azuma Y; Kiyoki M; Okumura H; Hashimoto K; Yoshikawa K
Biochim Biophys Acta; 1991 May; 1092(3):311-8. PubMed ID: 1646640
[TBL] [Abstract][Full Text] [Related]
13. 1alpha,25-Dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1alpha,25-dihydroxyvitamin D3: its production and metabolism in primary human keratinocytes.
Astecker N; Reddy GS; Herzig G; Vorisek G; Schuster I
Mol Cell Endocrinol; 2000 Dec; 170(1-2):91-101. PubMed ID: 11162893
[TBL] [Abstract][Full Text] [Related]
14. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
15. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
16. Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.
Tuckey RC; Li W; Shehabi HZ; Janjetovic Z; Nguyen MN; Kim TK; Chen J; Howell DE; Benson HA; Sweatman T; Baldisseri DM; Slominski A
Drug Metab Dispos; 2011 Sep; 39(9):1577-88. PubMed ID: 21677063
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism.
Cross HS; Peterlik M; Reddy GS; Schuster I
J Steroid Biochem Mol Biol; 1997 May; 62(1):21-8. PubMed ID: 9366495
[TBL] [Abstract][Full Text] [Related]
18. Extrarenal sites of calcitriol synthesis: the particular role of the skin.
Lehmann B; Meurer M
Recent Results Cancer Res; 2003; 164():135-45. PubMed ID: 12899518
[TBL] [Abstract][Full Text] [Related]
19. Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3.
Reichel H; Koeffler HP; Norman AW
Arch Biochem Biophys; 1986 Nov; 251(1):222-31. PubMed ID: 3024572
[TBL] [Abstract][Full Text] [Related]
20. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]